colm leonard
@LeonardColm
Followers
295
Following
1K
Media
1
Statuses
102
NHS Consultant Chest Physician; Honorary Professor of Respiratory Medicine; Chief Clinical Officer INFEX Therapeutics: AMR & sustainable antimicrobial pipeline
United Kingdom
Joined July 2019
I am biased but this is a fabulous interstitial lung disease course. Best to get registered quickly as it is usually oversubscribed
Join as at the Manchester Interstitial Lung Diseases (MILD) 2026 on 26th/27th March @ConalHayton @LeonardColm @CristinaAvram8 @JBlaikley Booking link below!
0
0
0
Be wary of using @FedEx for deliveries from USA to UK. My new stethoscope arrived in UK one week ago & I still have not received it. FedEx live chat & phone numbers do not allow human conversation! Appalling service
10
0
1
Beware flying with @FlyLoganair as my Wife experiencing terrible customer service Manchester to Aberdeen . Flew yesterday to Aberdeen, no baggage put on plane, told it would be on following flight, 2 flights later bag still in Manchester. Loganair unhelpful as is handling agent
1
0
1
Very excited to work with Asian ADVANCE-ID network to plan clinical trials of our novel metallo-beta-lactamase (MBL) inhibitor, MET-X. Antimicrobials targeting MBL mechanism of Gram negative bacterial resistance to antibiotics is key gap in pipeline. @davidantibiotic @INFEX_TX
Infex agrees collaboration with Asian clinical trials network, ADVANCE-ID Memorandum of Understanding signed to investigate hospital-acquired drug-resistant infections in Asia: https://t.co/XGywbHjNug
1
6
16
Excited to share our licensing deal in India for clinical development of MET-X our novel metallobetalactamase (MBL) inhibitor. MBL mechanism of resistance is an enormous problem in India & SE Asia & a rising problem EU & USA. MBL mechanism is a key pipeline priority for WHO
Infex signs exclusive license agreement with Venus Remedies Ltd to advance MET-X through clinical development and commercialisation in India: https://t.co/MKHz8q81k8
0
0
2
Novel pathways to combat antimicrobial resistance sorely needed. Its super that with this PACE funding INFEX & the team at Justus-Liebig-University Giessen can now advance this exciting BamA inhibitor project towards clinical trial readiness
Infex and Justus-Liebig-University Giessen awarded £1 million grant from PACE: https://t.co/VCxzbNPdy0
0
5
13
📊 New data from @UKHSA: Antibiotic-resistant infections in 2023 exceeded pre-pandemic levels An alarming 66,730 serious cases were reported - compared to 62,314 in 2019. 👉 https://t.co/jxqod3aWKl
gov.uk
There were an estimated 66,730 serious antibiotic-resistant infections in 2023.
0
8
8
This is scary, warzone superbugs come to visit! Funders, regulators, HTA entities need to facilitate antibiotic pipeline to have necessary armoury to fight this threat. Antimicrobial resistance is not a silent threat. Antimicrobial BioTech needs support
hsph.harvard.edu
The latest public health news delivered right to your inbox.
0
0
4
Looks like a super programme, thanks for sharing Chris.
Looking forward to chairing the Antimicrobial Chemotherapy Conference next week (6-7th Feb). It's a free virtual meeting organised jointly by GARDP and BSAC with an exciting programme covering the whole antimicrobial development pathway. Register Here: https://t.co/oRgTu9I0SI
0
0
5
📣 @INFEX_TX is on a mission to combat new COVID strains and is searching for a global pharma partner. Read more about their new treatment for COVID variants below ⬇️
thebusinessdesk.com
Tests on living organisms showed promising results
0
2
4
Infex Therapeutics Clinical candidate nominated for COV-X programme 📈COV-X outperforms Pfizer's approved antiviral 🌟Unique target: potential for broad efficacy against new coronaviruses 🦠Emerging resistance to existing Mpro inhibitors https://t.co/fOYNGmPn2o
#COVID19
0
3
6
Alarming antibiotic resistance discovered in war-torn Ukraine- this is truly frightening, the not so silent pandemic of AMR, 10% resistance to Colistin!
medicalxpress.com
Researchers led by Lund University in Sweden have assisted microbiologists in Ukraine in investigating bacterial resistance among the war-wounded patients treated in hospitals. The results, which...
0
3
11
We are recruiting healthy volunteers for a trial with @INFEX_TX. The full details are below 👇 Contact us to find out how you can #GetInvolvedinResearch
@LivHospitalsRI @LivHospitals
0
3
3
Questions about the UK Subscription Program for Antibacterials? See our Open Access article out today. Kudos to Team UK for leading the world. https://t.co/Vd1L5pij4z w @JohnRex_NewAbx
link.springer.com
Applied Health Economics and Health Policy -
2
18
37
Can the UK 'Netflix' Payment Model Boost the Antibacterial Pipeline? - PubMed
pubmed.ncbi.nlm.nih.gov
The silent pandemic of antimicrobial resistance (AMR) is a global issue needing prompt attention. A comprehensive one-health approach across human and animal health, agriculture and the environment...
0
10
17
'Can the UK's Netflix payment model boost the antibacterial pipeline?' Great insights on the how the project was devised & developed - sharing lessons learned - from @LeonardColm and team: https://t.co/7YDb2Z0Qy9
#pullincentives #antibioticresistance #innovation
pubmed.ncbi.nlm.nih.gov
The silent pandemic of antimicrobial resistance (AMR) is a global issue needing prompt attention. A comprehensive one-health approach across human and animal health, agriculture and the environment...
Delighted to share our publication on the NICE & NHS England project to deliver novel value assessment & reimbursement for new antimicrobial @NICEComms @NHSEngland
0
1
0
Delighted to share our publication on the NICE & NHS England project to deliver novel value assessment & reimbursement for new antimicrobial @NICEComms @NHSEngland
1
2
4
🚨 Northern Ireland and Manchester Interstitial Lung Disease Course which will be held on 2nd -3rd March 2023 🚨 #Manchester 🇬🇧 🫁 #ILD #CTD_ILD #PFILD #PostCOVID_ILD #AEILD #MDT 🫁 We look forward to seeing you there! You can see the programme and the link to register below 👇
Dear #ILD Colleague, I am delighted to invite you to the Northern Ireland and Manchester Interstitial Lung Diseases Meeting which will be held on 2-3 March 2023. To register your place please visit the following link to Eventbrite: https://t.co/5bDCw1v2jU Category 13 CPD credits
0
9
23
Very proud of Lucy judging ice dance Grand Prix final in Turin
0
0
3